SCHEMBL21846220

SCHEMBL21846220

CCCN(C[C@H](CC#N)CCC(=O)/C=C/COC)c1nc(OC[C@H](C)C[C@@H](F)CC)nc(CC)c1CCCCc1cccc2cccc(C)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21846381 0.78 — —
SCHEMBL21846313 0.73 — —
SCHEMBL25020089 0.71 — —
SCHEMBL21895625 0.70 — —
SCHEMBL22010340 0.69 — —
SCHEMBL25020002 0.68 — —
SCHEMBL21912778 0.67 — —
SCHEMBL22086717 0.66 — —
SCHEMBL25021821 0.62 — —
SCHEMBL21846275 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055760-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback